Bioactive peptides—naturally occurring or engineered sequences that modulate biological processes—form the basis of many current and emerging therapeutics. The peptide therapeutics market is expected to reach $83.57 billion in 2030 at a CAGR of 11.2%[reference:103], reflecting the growing importance of these molecules in modern medicine.
Natural bioactive peptides include hormones (insulin, glucagon), neurotransmitters (substance P, neuropeptide Y), and antimicrobial peptides (defensins, cathelicidins). These molecules play essential roles in physiological regulation, and their dysregulation is associated with numerous diseases. Understanding the structure and function of natural bioactive peptides has provided a foundation for therapeutic development.
Engineered bioactive peptides are designed to improve upon natural sequences, enhancing potency, stability, and pharmacokinetic properties. Examples include GLP-1 receptor agonists (semaglutide, liraglutide) for diabetes and obesity, and antimicrobial peptides optimized for stability and reduced toxicity.
Bioactive peptides offer several advantages as therapeutics. They have high specificity for their targets, reducing off-target effects. They are generally well-tolerated with low immunogenicity. Their synthetic accessibility allows for rapid optimization and modification. These advantages have made bioactive peptides attractive candidates for drug development across multiple therapeutic areas.
At PeptideHub, we supply a comprehensive range of bioactive peptides for research applications. Our catalog includes hormones, neurotransmitters, antimicrobial peptides, and cell-penetrating peptides. We also offer custom synthesis of bioactive peptide analogs for SAR studies and optimization. Our commitment to quality ensures that you receive peptides with the purity and activity needed for your research.